Martingale Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $293K | Sell |
25,145
-33,180
| -57% | -$387K | 0.01% | 709 |
|
|
2025
Q1 | $433K | Sell |
58,325
-296
| -0.5% | -$2.2K | 0.01% | 625 |
|
|
2024
Q4 | $351K | Hold |
58,621
| – | – | 0.01% | 662 |
|
|
2024
Q3 | $300K | Buy |
58,621
+21
| +0% | +$108 | 0.01% | 709 |
|
|
2024
Q2 | $212K | Sell |
58,600
-108
| -0.2% | -$391 | ﹤0.01% | 752 |
|
|
2024
Q1 | $188K | Hold |
58,708
| – | – | ﹤0.01% | 784 |
|
|
2023
Q4 | $288K | Buy |
58,708
+3,900
| +7% | +$19.1K | 0.01% | 707 |
|
|
2023
Q3 | $299K | Buy |
54,808
+3,504
| +7% | +$19.1K | 0.01% | 685 |
|
|
2023
Q2 | $344K | Sell |
51,304
-4,200
| -8% | -$28.2K | 0.01% | 679 |
|
|
2023
Q1 | $490K | Buy |
55,504
+37
| +0.1% | +$327 | 0.01% | 622 |
|
|
2022
Q4 | $424K | Buy |
55,467
+8,513
| +18% | +$65K | 0.01% | 653 |
|
|
2022
Q3 | $335K | Buy |
46,954
+20,554
| +78% | +$147K | 0.01% | 698 |
|
|
2022
Q2 | $214K | Buy |
+26,400
| New | +$214K | ﹤0.01% | 799 |
|